AMY GLEATON: Open Payments
NPI 1255967154 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 93 payments from 19 companies in 2025. Trend: 2023 $321 · 2024 $1,572 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $465 |
| Novo Nordisk Inc | 11 | $230 |
| ABBVIE INC. | 16 | $182 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Amgen Inc. | 3 | $47 |
Products named: NURTEC ODT, Ozempic, ELIQUIS, UBRELVY, AIRSUPRA, Kerendia, JARDIANCE, SHINGRIX.
Industry payments across FL — which companies pay providers there.
